These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 15521374

  • 1. Observational study of the effects of using montelukast vs fluticasone in patients matched at baseline.
    Allen-Ramey FC, Duong PT, Riedel AA, Markson LE, Weiss KB.
    Ann Allergy Asthma Immunol; 2004 Oct; 93(4):373-80. PubMed ID: 15521374
    [Abstract] [Full Text] [Related]

  • 2. Asthma-related health care resource use among patients starting fluticasone or montelukast therapy.
    Allen-Ramey FC, Anstatt DT, Sajjan SG, Markson LE.
    Pharmacotherapy; 2005 Dec; 25(12):1752-60. PubMed ID: 16305295
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies.
    Stoloff SW, Stempel DA, Meyer J, Stanford RH, Carranza Rosenzweig JR.
    J Allergy Clin Immunol; 2004 Feb; 113(2):245-51. PubMed ID: 14767437
    [Abstract] [Full Text] [Related]

  • 7. Adherence to asthma controller medication regimens.
    Stempel DA, Stoloff SW, Carranza Rosenzweig JR, Stanford RH, Ryskina KL, Legorreta AP.
    Respir Med; 2005 Oct; 99(10):1263-7. PubMed ID: 16140227
    [Abstract] [Full Text] [Related]

  • 8. Comparison of asthma costs in patients starting fluticasone propionate compared to patients starting montelukast.
    Stempel DA, Mauskopf J, McLaughlin T, Yazdani C, Stanford RH.
    Respir Med; 2001 Mar; 95(3):227-34. PubMed ID: 11266241
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparative efficacy and cost of asthma care in children with asthma treated with fluticasone propionate and montelukast.
    Stempel DA, Kruzikas DT, Manjunath R.
    J Pediatr; 2007 Feb; 150(2):162-7. PubMed ID: 17236894
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Montelukast, compared with fluticasone, for control of asthma among 6- to 14-year-old patients with mild asthma: the MOSAIC study.
    Garcia Garcia ML, Wahn U, Gilles L, Swern A, Tozzi CA, Polos P.
    Pediatrics; 2005 Aug; 116(2):360-9. PubMed ID: 16061590
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Economic impact of asthma therapy with fluticasone propionate, montelukast, or zafirlukast in a managed care population.
    Pathak DS, Davis EA, Stanford RH.
    Pharmacotherapy; 2002 Feb; 22(2):166-74. PubMed ID: 11837555
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.